CHICAGO, IL—The choice of loop diuretic doesn’t make a difference in how patients hospitalized for heart failure fare, at least when it comes to their risk of dying or of being readmitted, the ...
Outcomes from the loop diuretics were compared in this analysis, with study participants from the TRANSFORM-HF trial matched 1:1, all having been hospitalized for either do novo disease or worsening ...
SCHAUMBURG, Ill.--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Furosemide for Injection in the ...
Uncertainty regarding diuretic efficacy and optimal dosing in hemodialysis likely contributes to practice variation, according to investigators. A new study finds “substantial” variation in oral ...
Please provide your email address to receive an email when new articles are posted on . scPharmaceuticals Inc. announced the FDA approved its self-administered subcutaneous furosemide injection for ...
CHICAGO -- The choice between furosemide and torsemide didn't matter for longer-term clinical outcomes of hospitalized heart failure patients, according to the comparative effectiveness trial ...
A clinical trial funded by the National Institute of Health (NIH) revealed there is no significant difference in the effectiveness of furosemide and torsemide, two heart failure drugs, when it comes ...
Swollen arms, legs or ankles can be telltale signs your body is carrying more water and salt than normal, making moving pretty uncomfortable. About 50-65% of your body is water, and maintaining a ...
Long-term partnership secures high-quality active pharmaceutical ingredient supply for Lasix(R) ONYU and future pipeline products BURLINGTON, Mass. and VICENZA, Italy, April 15, 2026 /PRNewswire/ -- ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results